Social Media Content Creators Driving Parallel Market for Unlicensed Slimming Drug
A shadow economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.
Investigational Treatment Gaining Popularity Online
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Followers are urged to message these accounts directly for source information, while also obtaining promotional offers.
Active Trade on Social Networks
Additionally, a flourishing market exists on Telegram, where communities with thousands of members share “before and after” photos, administration instructions and assertions of rapid UK delivery. Vendors promote the drug there before redirecting customers to other platforms for transactions.
Learning About Retatrutide
Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.
Medical Professionals Express Worries
However, physicians and pharmacists have cautions that the sale of what is still an unapproved drug in the UK is worrisome and could result in users administering products of uncertain source.
Some experts said the demand for the experimental drug could be linked to the rising cost of licensed weight loss products such as Mounjaro.
Regulatory Position and Implementation
Selling the unapproved drug on social media or Telegram is illegal in the UK, as it is an unapproved drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Some content creators attempt to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still breach medicines, advertising, and consumer laws, potentially leading to fines, legal action or imprisonment.
Platform Reaction and Content Elimination
According to TikTok, the service has removed violative content and prohibited associated hashtags and search suggestions. The organization said it was dedicated to maintaining the service secure and allocating resources in enhancing compliance measures.
Online Marketplace Activities
Investigations also discovered groups with up to 9,000 members selling the experimental drug using the platform's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly displays channels with numerous of users, populated with photos of slimming results, positive testimonials and step-by-step instructions for preparing or injecting at home.
Within moments of entering one community, a vendor shared WhatsApp details, where most purchases occur. The vendor sent an instruction manual and promised delivery within two days. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about weight, medical conditions or previous experience.
Item Details and Pricing
Within these communities, posts show dark colored parcels with postal service stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at home with purified liquid, or pre-filled pens typically sold at £160 for 20 milligrams. When questioned how long a injector should be used, sellers give conflicting responses ranging from a few weeks to “depends on your body”.
Platform Oversight and Safety Measures
A representative for Telegram stated it actively monitored harmful material on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are injecting materials they can’t verify. Although the research behind this drug is sound, these online versions may not include what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
A medical professional of an online medical service connected the increase in interest to current price rises for authorized weight-loss medications such as Mounjaro. “With costs increasing, patients are turning to social media. But fake injections are highly risky. You cannot know what’s contained or whether the environment they were produced in was sterile,” she said.
Her team has previously encountered patients injured by self-injection from unverified sources. “We understand the disappointment, but buying from Telegram or communication platforms is taking chances with your well-being,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Position
A spokesperson from Eli Lilly said retatrutide was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a Lilly investigational substance not yet approved … may expose users to possibly significant health risks”.
